Saluda Medical Pty. Ltd. has had a busy summer. First, it revealed results from two clinical studies evaluating its Evoke ECAP-controlled closed-loop spinal cord stimulation system and its impact on those suffering from chronic pain. It subsequently won some backing from two major medical device players: Marlborough, Mass.-based Boston Scientific Corp. and Medtronic plc, of Dublin.